| Market Cap | $4.5M | |
| Enterprise Value | $5.5M | |
| Revenue | $59.1M | — |
| Gross Profit | $10.8M | — |
| EBITDA | -$3.9M | −342.0% |
| Net Income | -$14.8M | — |
| Diluted EPS | — | — |
| Free Cash Flow | -$17.6M | — |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | 23.77% | 11.75% | 16.65% | 20.64% | 17.02% | — | — | — | |
| Operating Margin | −45.72% | −69.64% | −20.46% | 0.55% | −5.32% | — | — | — | |
| EBITDA Margin | −41.46% | −65.74% | −17.06% | 2.90% | 0.78% | — | — | — | |
| NOPAT Margin | −36.12% | −55.01% | −16.17% | 0.00% | −4.20% | — | — | — | |
| Net Margin | −46.77% | −70.78% | −20.17% | −0.10% | −57.72% | — | — | — | |
| FCF Margin | −16.52% | −70.59% | −17.71% | −4.37% | −14.92% | — | — | — | |
| FCFE Margin | −23.00% | −70.86% | −17.81% | — | — | — | — | — | |
| OCF Margin | −16.50% | −70.51% | −17.70% | −4.33% | −14.56% | — | — | — | |
| Gross Profitability | 30.23% | 15.61% | 21.65% | 34.48% | 24.96% | — | — | — | |
| Capex Intensity | 0.02% | 0.08% | 0.01% | 0.04% | 0.37% | — | — | — | |
| ▸Returns on Capital · 6 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||||
| ▸Earnings quality · 4 ratios | |||||||||
| ▸Liquidity & coverage · 8 ratios | |||||||||
| ▸Leverage · 8 ratios | |||||||||
| ▸Working capital · 8 ratios | |||||||||
| ▸Per share · 6 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
The five drivers multiply to -0.4% vs reported ROE -0.4%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2020↗ | 2021↗ | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|---|---|
| Revenue | $64.0M | $54.6M | $69.8M | $93.6M | $58.3M | — |
| YoY % | -14.7% | +28.0% | +34.1% | -37.7% | ||
| Cost of Revenue | $48.8M | $48.2M | $58.2M | $74.3M | $48.4M | — |
| YoY % | -1.3% | +20.9% | +27.7% | -34.9% | ||
| Gross Profit | $15.2M | $6.4M | $11.6M | $19.3M | $9.9M | — |
| YoY % | -57.8% | +81.2% | +66.3% | -48.7% | ||
| R&D Expense | $16.2M | $17.7M | $8.0M | $1.8M | $14.2M | — |
| YoY % | +9.1% | -54.9% | -77.8% | +703.3% | ||
| Selling & Marketing Expense | $10.4M | $9.6M | $7.3M | $8.8M | $13.0M | — |
| YoY % | -8.1% | -24.0% | +20.5% | +47.8% | ||
| SG&A Expense | $9.8M | $10.3M | $10.7M | $8.3M | $3.1M | $5.4M |
| YoY % | +4.6% | +3.7% | -22.5% | -62.5% | +74.4% | |
| Total Operating Expenses | $44.5M | $44.4M | $25.9M | $18.8M | $3.1M | $5.4M |
| YoY % | -0.1% | -41.7% | -27.4% | -83.5% | +74.4% | |
| Operating Income | -$29.3M | -$38.0M | -$14.3M | $513,000 | -$3.1M | -$5.4M |
| Interest Expense | — | — | $97,000 | — | — | $945,000 |
| Other Non-Operating Income | -$434,000 | -$459,000 | $484,000 | -$214,000 | $246,000 | -$902,000 |
| Impairment of Real Estate | — | — | — | — | $6.5M | $2.1M |
| YoY % | -68.1% | |||||
| Pretax Income | -$30.5M | -$38.5M | -$13.9M | $284,000 | -$2.9M | -$8.0M |
| Income Tax | -$521,000 | $167,000 | $184,000 | $374,000 | $226,000 | -$1.1M |
| YoY % | +10.2% | +103.3% | -39.6% | |||
| Income from Continuing Operations | — | — | — | — | -$2.9M | -$8.0M |
| Income from Discontinued Operations | — | — | — | — | -$30.8M | -$12.7M |
| Net Income (incl. NCI) | -$29.9M | -$38.6M | — | — | — | -$20.7M |
| Net Income | -$29.9M | -$38.6M | -$14.1M | -$90,000 | -$33.6M | -$20.7M |
| EPS (Basic) | — | -$4.08 | -$0.49 | -$0.02 | -$128.37 | -$28.58 |
| EPS (Diluted) | — | — | -$0.49 | -$0.02 | -$128.37 | -$28.58 |
| Weighted Avg Shares (Basic) | — | 9.5M | 28.9M | 4.3M | 262,118 | 722,689 |
| YoY % | +205.2% | -85.2% | -93.9% | +175.7% | ||
| Weighted Avg Shares (Diluted) | — | — | 28.9M | 4.3M | 262,118 | 722,689 |
| YoY % | -85.2% | -93.9% | +175.7% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
